to investigate the destruction of the 30-acre DPS Flamingo Lake and submit a report within 15 days. The department has also sought an action-taken report following environmentalists’ complaints ...
The expansion of FLAMINGO-01 into Europe has been complimentary to the activated sites in the US, which also increased in 2024. In total we now have approximately 100 sites globally that are activated ...
CEO Snehal Patel expressed optimism about site activation in Europe mirroring U.S. efforts, with approximately 100 sites currently screening patients globally. FLAMINGO-01 will evaluate GLSI-100's ...
announced that its application seeking expansion of its FLAMINGO-01 clinical trial in Europe has been approved by the European Medicines Agency. FLAMINGO-01 is a phase III clinical trial ...
FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, provided the following update on the expansion of the clinical trial into Europe. The Company’s ...